EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
WATERTOWN, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that EyePoint Pharmaceuticals will present at the following upcoming conferences:
Related news for (EYPT)
- Breaking News: MoBot’s Latest Update as of 05/28/25 12:00 PM
- eyepoint pharmaceuticals announces closing of upsized public offering and full exercise of option to purchase additional shares
- eyepoint pharmaceuticals announces pricing of upsized public offering
- eyepoint pharmaceuticals announces proposed public offering of common stock
- 24/7 Market News Snapshot 28 October, 2024 – EyePoint Pharmaceuticals, Inc. Common Stock (NASDAQ:EYPT)